Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) Research & Development (2016 - 2025)

Historic Research & Development for Ocugen (OCGN) over the last 12 years, with Q3 2025 value amounting to $11.1 million.

  • Ocugen's Research & Development rose 3750.62% to $11.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.4 million, marking a year-over-year increase of 1820.34%. This contributed to the annual value of $32.1 million for FY2024, which is 1881.84% down from last year.
  • Latest data reveals that Ocugen reported Research & Development of $11.1 million as of Q3 2025, which was up 3750.62% from $8.4 million recorded in Q2 2025.
  • Ocugen's 5-year Research & Development high stood at $18.9 million for Q2 2021, and its period low was $2.9 million during Q1 2021.
  • Its 5-year average for Research & Development is $10.1 million, with a median of $8.9 million in 2024.
  • Per our database at Business Quant, Ocugen's Research & Development skyrocketed by 105662.58% in 2021 and then crashed by 6070.69% in 2023.
  • Quarter analysis of 5 years shows Ocugen's Research & Development stood at $7.1 million in 2021, then skyrocketed by 142.57% to $17.2 million in 2022, then plummeted by 54.84% to $7.8 million in 2023, then rose by 6.57% to $8.3 million in 2024, then surged by 34.49% to $11.1 million in 2025.
  • Its Research & Development was $11.1 million in Q3 2025, compared to $8.4 million in Q2 2025 and $9.5 million in Q1 2025.